ArticleFrontiers in immunology2026
NECSO-based classification predicts immunotherapy efficacy and identifies FLAD1 as therapeutic target in kidney renal clear cell carcinoma.
Yitong Pan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.